首页> 外文期刊>Antimicrobial agents and chemotherapy. >Omeprazole antagonizes virulence and inflammation in Salmonella enterica-infected RAW264.7 cells.
【24h】

Omeprazole antagonizes virulence and inflammation in Salmonella enterica-infected RAW264.7 cells.

机译:奥美拉唑拮抗肠炎沙门氏菌感染的RAW264.7细胞的毒性和炎症。

获取原文
获取原文并翻译 | 示例
           

摘要

The proton pump inhibitor omeprazole reduced the intracellular replication of Salmonella enterica serovar Typhimurium in RAW264.7 cells without affecting bacterial growth in vitro or the viability of the host cells. The mechanism was bacteriostatic and interfered with replication mediated by the virulence-associated SPI2 type III secretion system. The proton pump inhibitor bafilomycin A(1), in contrast, mediated killing of intracellular bacteria and imposed a marked cytotoxicity on RAW264.7 cells. The two compounds also differentially affected the proinflammatory responses of the infected cells. Bafilomycin A(1) enhanced nitric oxide production, whereas omeprazole delayed IkappaB degradation and blocked nitric oxide production and the secretion of proinflammatory cytokines. These results imply that omeprazole can be used to block the virulence factor-mediated intracellular replication of S. Typhimurium, and that its mechanism of growth inhibition is different from that mediated by bafilomycin A(1).
机译:质子泵抑制剂奥美拉唑可降低RAW264.7细胞中肠炎沙门氏菌鼠伤寒沙门氏菌的细胞内复制,而不会影响体外细菌生长或宿主细胞的活力。该机制是抑菌的,并干扰由毒力相关的SPI2 III型分泌系统介导的复制。相比之下,质子泵抑制剂bafilomycin A(1)介导杀死细胞内细菌,并对RAW264.7细胞施加明显的细胞毒性。两种化合物还差异地影响感染细胞的促炎反应。 Bafilomycin A(1)增强一氧化氮的产生,而奥美拉唑则延迟IkappaB降解并阻止一氧化氮的产生和促炎细胞因子的分泌。这些结果表明,奥美拉唑可用于阻断鼠伤寒沙门氏菌的毒力因子介导的细胞内复制,并且其生长抑制机制与巴氟霉素A(1)介导的机制不同。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号